Felix Baker, Director at ALEXION PHARMACEUTICALS, INC. (ALXN), sold 295,700 shares at $120.12 ($36.6M) on 2019-05-30, disclosed to the SEC on 2019-05-30.
Open-market sale of $36.6M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.05 | 22,886 | $2.9M | 7.8% |
| 2 | $125.05 | 2,749 | $344K | 0.9% |
| 3 | $126.25 | 1,867 | $236K | 0.6% |
| 4 | $126.25 | 15,541 | $2.0M | 5.4% |
| 5 | $127.06 | 8,627 | $1.1M | 3.0% |
| 6 | $127.06 | 71,819 |
| $9.1M |
| 24.9% |
| 7 | $121.37 | 39,732 | $4.8M | 13.2% |
| 8 | $121.37 | 4,772 | $579K | 1.6% |
| 9 | $122.37 | 35,796 | $4.4M | 12.0% |
| 10 | $123.06 | 30,766 | $3.8M | 10.3% |
| 11 | $123.06 | 3,696 | $455K | 1.2% |
| 12 | $120.12 | 1,845 | $222K | 0.6% |
| 13 | $120.12 | 15,355 | $1.8M | 5.0% |
| 14 | $120.77 | 2,729 | $330K | 0.9% |
| 15 | $120.77 | 22,720 | $2.7M | 7.5% |
| 16 | $122.31 | 1,587 | $194K | 0.5% |
| 17 | $122.31 | 13,213 | $1.6M | 4.4% |
| Total | $123.77 avg | 295,700 | $36.6M | 100% |
| Filing → |
| MDGL | BUY | 2025-08-20 | $48.5M | — | Filing → |
| KALA | BUY | 2024-12-31 | $4.0M | — | Filing → |
| MDGL | BUY | 2023-11-15 | $31.4M | — | Filing → |